Patents by Inventor Ying Yee

Ying Yee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vitamin d receptor modulators
    Publication number: 20070149810
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-benzothiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: June 28, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Jianliang Lu, Tainwei Ma, Sunil Nagpal, Quanrong Shen, Alan Warshawsky, Ying Yee, Michael Rupp
  • Phenyl-furan compounds as vitamin d receptor modulators
    Publication number: 20070105951
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-furan compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: May 10, 2007
    Inventors: Robert Gajewski, Charles Jones, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Yee
  • Vitamin d receptor modulators
    Publication number: 20070106095
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 16, 2004
    Publication date: May 10, 2007
    Inventors: Jianliang Lu, Tianwei Ma, Sunil Nagpal, Quanrong Shen, Alan Warshawsky, Jason Ochoada, Ying Yee
  • Antithrombotic aromatic ethers
    Publication number: 20070027185
    Abstract: This application relates to a compound of formula I (or a prodrug thereof or a pharmaceutically acceptable salt of the compound or prodrug thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa and/or thrombin, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: September 24, 2004
    Publication date: February 1, 2007
    Applicant: ELILILLY AND COMPANY
    Inventors: Jeffry Franciskovich, Theodore Goodson, David Herron, Angela Marquart, John Masters, David Mendel, Leander Merritt, Andrew Ratz, Gerald Smith, Michael Wiley, Ying Yee
  • Vitamin d receptor modulators
    Publication number: 20060293385
    Abstract: The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: November 8, 2004
    Publication date: December 28, 2006
    Inventors: Robert Gajewski, Charles Jones, Jared Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Ying Yee
  • Phenyl-thiophene type vitamin d receptor modulators
    Publication number: 20060287536
    Abstract: The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1?,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
    Type: Application
    Filed: May 22, 2003
    Publication date: December 21, 2006
    Inventors: Karl Dahnke, Robert Gajewski, Charles Jones, Jared Linebarger, Jianliang Lu, Tianwei Ma, Sunil Nagpal, Todd Simard, Ying Yee, Emilio Bunel, Ryan Stites
  • Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
    Publication number: 20060135484
    Abstract: The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, phenylthiophene compound with vitamin D receptor (VDR) modulating activity.
    Type: Application
    Filed: January 7, 2004
    Publication date: June 22, 2006
    Applicant: Eli Lilly and Company Patent Divison
    Inventors: Sunil Nagpal, Ying Yee
  • Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators
    Publication number: 20060094778
    Abstract: The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, diphenyl compound with vitamin D receptor (VDR) modulating activity.
    Type: Application
    Filed: January 7, 2004
    Publication date: May 4, 2006
    Inventors: Sunil Nagpal, Ying Yee
  • Aromatic amides
    Publication number: 20050282862
    Abstract: This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.
    Type: Application
    Filed: July 29, 2003
    Publication date: December 22, 2005
    Inventors: Douglas Beight, Trelia Craft, Carl Denny, Jeffry Franciskovich, Theodore Goodson, Steven Hall, David Herron, Sajan Joseph, Valentine Klimkowski, Jeffrey Kyle, John Masters, David Mendel, Guy Milot, Marta Pineiro-Nunez, Jason Sawyer, Robert Shuman, Gerald Smith, Anne Tebbe, Jennifer Tinsley, Leonard Weir, James Wikel, Michael Wiley, Ying Yee